FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

NCI website aids cancer trial recruitment

Free Newsletter

FierceBiotech IT updates senior biotech, pharma, and IT leaders on how IT advances are shaping clinical trials and clinical research. Get your weekly briefing on clinical trial design and management systems, adaptive trials, eClinical trials, and more. Sign up today!



Tools

An online tool lets cancer researchers collaborate and commiserate on subject recruitment. Much of the accumulated knowledge on cancer trial recruitment is scattered among those who have conducted the trials. Some appears in literature.

AccrualNet, developed by the National Cancer Institute and unveiled at the recent Cancer Trial Accrual Symposium, functions as an aggregator of this knowledge and makes it accessible to the cancer research community. The goals of the site are to increase knowledge about the processes needed for success in clinical trial accrual, and to encourage use of available resources. The site and the project that led to it are described in a recent NCI Cancer Bulletin special issue devoted to trials enrollment.

The developers have created a community of practice, to which visitors contribute materials, tips, experience, and practices. An annotated list of journal articles on trial recruitment and links to relevant publications are included, as well as tools to aid recruitment efforts.

- see the article

Related Articles:
Marketing, multimedia aid recruitment
Facebook privacy upgrade foretells trial tool
Pharma, social media continue dance


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotechIT Email Newsletter:

More stories about clinical trials   patient recruitment   website